QSAR analysis of meclofenamic acid analogues as selective COX-2 inhibitors

被引:23
|
作者
Narsinghani, T
Chaturvedi, SC
机构
[1] SGSITS, Dept Pharm, Indore, India
[2] DAVV, Sch Pharm, Indore, India
关键词
COX-1/COX-2/MOE/QSAR/meclofenamic acid analogues;
D O I
10.1016/j.bmcl.2005.07.067
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The use of quantitative structure-activity relationships, since its advent, has become increasingly helpful in understanding many aspects of biochemical interactions in drug research. This approach was utilized to explain the relationship of structure with biological activity of selective COX-2 inhibitors. The enormity of the COX-2 discovery is reflected in the unprecedented speed at which research laboratories have sought to validate its clinical implications. Presented herein is a series of 21 derivatives of meclofenamic acid with selective COX-2 inhibitory activity. Several statistically significant regression expressions were obtained for both COX-1 and COX-2 inhibition using sequential multiple linear regression analysis method. Two of these models were selected and validated further, which revealed the importance of Kier molecular flexibility index for COX-2 inhibitory activity and the number of hydrogen bond donor atoms for COX-1 inhibitory activity. Additionally, linear correlation of molecular flexibility with COX-1 and COX-2 inhibitory activities revealed that flexibility of molecules at COX-2 active site can improve the selectivity of COX-2 inhibitors. (c) 2005 Published by Elsevier Ltd.
引用
收藏
页码:461 / 468
页数:8
相关论文
共 50 条
  • [1] Thiazole analogues of the NSAID indomethacin as selective COX-2 inhibitors
    Woods, KW
    McCroskey, RW
    Michaelides, MR
    Wada, CK
    Hulkower, KI
    Bell, RL
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (10) : 1325 - 1328
  • [2] Selective inhibitors of COX-2
    不详
    EXPERT OPINION ON THERAPEUTIC PATENTS, 1996, 6 (01) : 79 - 80
  • [3] Selective COX-2 inhibitors
    Parnham, MJ
    DRUG NEWS & PERSPECTIVES, 1997, 10 (03) : 182 - 187
  • [4] Selective COX-2 inhibitors
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1997, 2 (03) : 122 - 122
  • [5] Selective COX-2 inhibitors
    Pasero, C
    McCaffery, M
    AMERICAN JOURNAL OF NURSING, 2001, 101 (04) : 55 - 56
  • [6] 2D QSAR STUDY OF INDOLE DERIVATIVES AS SELECTIVE COX-2 INHIBITORS
    Chavan, R. S.
    More, H. N.
    Bhosale, A., V
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2019, 10 (07): : 3378 - 3385
  • [7] Arylidene analogues as selective COX-2 inhibitors: synthesis, characterization,in silicoandin vitrostudies
    Namera, Dipti L.
    Thakkar, Sampark S.
    Thakor, Parth
    Bhoya, Umed
    Shah, Anamik
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (18): : 7150 - 7159
  • [8] Structurally Modified Celecoxib Analogues for Selective COX-2 Inhibition: a Classical Hansch QSAR Approach
    Manivannan, E.
    Moorthy, N. S. H. N.
    LATIN AMERICAN JOURNAL OF PHARMACY, 2012, 31 (04): : 561 - 566
  • [9] COX-2 selective inhibitors and bone
    Goodman, SB
    Ma, T
    Genovese, M
    Smith, RL
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2003, 16 (03): : 201 - 205
  • [10] Are COX-2 selective inhibitors nephrotoxic?
    Dunn, MJ
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (05) : 976 - 977